Medicine Matters rheumatology
340 FOLLOWERS
Medicine Matters rheumatology is a resource for healthcare professionals looking for credible information on the latest advances in rheumatic diseases. Interviews with clinical experts, discussing key issues in rheumatology.
Medicine Matters rheumatology
3y ago
Philip Robinson discusses why TNF inhibitors may be a favorable treatment option for COVID-19 and outlines the trials that are currently underway ..read more
Medicine Matters rheumatology
3y ago
Cristina Mussini discusses the current data on interleukin inhibitors for the treatment of COVID-19 and explores why tocilizumab has been associated with beneficial outcomes in some studies but not others ..read more
Medicine Matters rheumatology
3y ago
Marwan Bukhari talks about the rationale behind investigating baricitinib and other JAK inhibitors for the treatment of COVID-19 and outlines the current efficacy data ..read more
Medicine Matters rheumatology
3y ago
In this series of podcasts we are speaking to the experts about repurposing rheumatology drugs for the treatment and prevention of COVID-19.
In this episode, Alfred (Al) Kim, a rheumatologist from the Washington University School of Medicine in St Louis, Missouri, USA, talks about hydroxychloroquine. He discusses why the drug was initially considered promising but later shown to be ineffective, and describes the impact drug shortages have had on rheumatology practice.
Find more on Medicine Matters rheumatology ..read more
Medicine Matters rheumatology
3y ago
In this series of podcasts we are speaking to the experts about repurposing rheumatology drugs for the treatment and prevention of COVID-19.
For the introductory podcast, Jinoos Yazdany, rheumatologist and Professor of Medicine at the University of California, San Francisco in the USA, talks about the rationale behind investigating these agents and the role of rheumatologists in ensuring they are studied as safely and efficiently as possible.
Find more on Medicine Matters rheumatology ..read more
Medicine Matters rheumatology
4y ago
In April 2020, the American College of Rheumatology issued guidance for the management of people with rheumatic diseases during the COVID-19 pandemic.
We spoke to lead author Ted Mikuls, from the University of Nebraska Medical Center in the USA, to find out more about what rheumatologists should do to best care for their patients in light of COVID-19, and what some of the unanswered questions are.
Find more on Medicine Matters rheumatology
Image credit: COVID-19 illustration © koto_feja/Getty Images/iStock ..read more
Medicine Matters rheumatology
4y ago
Philip Robinson, chair of the steering committee for the COVID-19 Global Rheumatology Alliance, tells us about the initiative that will enable rheumatologists to document their patient experiences of COVID-19 and contribute to a shared learning resource (17:28). Find more on Medicine Matters rheumatology Image credit: COVID-19 illustration © koto_feja/Getty Images/iStock ..read more
Medicine Matters rheumatology
4y ago
Sangeeta Sule, from Children’s National Hospital in Washington, DC, USA, shares her experience of how the pediatric rheumatology community is adapting to the COVID-19 pandemic, including the use of telemedicine practice. Find more on Medicine Matters rheumatology ..read more
Medicine Matters rheumatology
4y ago
Kevin Winthrop, from Oregon Health & Science University in Portland, USA, discusses why patients with rheumatic diseases may be vulnerable to COVID-19 and how different treatments may affect the risk for infection and prognosis of the disease. Find more on Medicine Matters rheumatology ..read more
Medicine Matters rheumatology
4y ago
Kevin Winthrop, from Oregon Health & Science University in Portland, USA, discusses why patients with rheumatic diseases may be vulnerable to COVID-19 and how different treatments may affect the risk for infection and prognosis of the disease. Find more on Medicine Matters rheumatology ..read more